These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19594208)

  • 1. Antisnake venom production crisis--who told us it was uneconomic and unsustainable?
    Simpson ID; Jacobsen IM
    Wilderness Environ Med; 2009; 20(2):144-55. PubMed ID: 19594208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time for an alternative perspective: the eternal problem of supply and quality of anti snake venom in the developing world--"it's the economy, stupid".
    Simpson ID
    Wilderness Environ Med; 2008; 19(3):186-94. PubMed ID: 18715131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti snake venom crisis in Africa: a suggested manufacturers product guide.
    Simpson ID; Blaylock RS
    Wilderness Environ Med; 2009; 20(3):275-82. PubMed ID: 19737031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global snakebite crisis--a public health issue misunderstood, not neglected.
    Simpson ID; Norris RL
    Wilderness Environ Med; 2009; 20(1):43-56. PubMed ID: 19364169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "worldwide shortage" of antisnake venom: is the only right answer "produce more" or is it also "use it smarter?".
    Simpson ID
    Wilderness Environ Med; 2008; 19(2):99-107. PubMed ID: 18513107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A locally developed snakebite management protocol significantly reduces overall anti snake venom utilization in West Bengal, India.
    Ghosh S; Maisnam I; Murmu BK; Mitra PK; Roy A; Simpson ID
    Wilderness Environ Med; 2008; 19(4):267-74. PubMed ID: 19099337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).
    Pradhan S; Kumar S; Singh D; Sood RC; Sehgal R
    Biologicals; 2007 Jun; 35(3):155-60. PubMed ID: 17088076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic biology tackles global antivenom shortage.
    Arnold C
    Nature; 2016 Apr; 532(7599):292. PubMed ID: 27111610
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of the current knowledge base in treating snake bite amongst doctors in the high-risk countries of India and Pakistan: does snake bite treatment training reflect local requirements?
    Simpson ID
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1108-14. PubMed ID: 18501936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised control trial on the effective dose of anti-snake venom in cases of snake bite with systemic envenomation.
    Seth AK; Varma PP; Pakhetra R
    J Assoc Physicians India; 2000 Jul; 48(7):756. PubMed ID: 11273522
    [No Abstract]   [Full Text] [Related]  

  • 11. Antisnake venom in a neonate with snake bite.
    Jindal G; Mahajan V; Parmar VR
    Indian Pediatr; 2010 Apr; 47(4):349-50. PubMed ID: 20431166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of disease burden due to land-snake bite in Sri Lankan hospitals.
    Kasturiratne A; Pathmeswaran A; Fonseka MM; Lalloo DG; Brooker S; de Silva HJ
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):733-40. PubMed ID: 16124448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivenom: the most cost-effective treatment in the world?
    Brown N; Landon J
    Toxicon; 2010 Jun; 55(7):1405-7. PubMed ID: 20171241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snake venoms and their toxins: an Australian perspective.
    Hodgson WC; Wickramaratna JC
    Toxicon; 2006 Dec; 48(7):931-40. PubMed ID: 16920171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In Africa snake venom antivenins in short supply. Fatal risk for foreign tourists?].
    Mebs D
    MMW Fortschr Med; 2002 Sep; 144(37):57. PubMed ID: 12380345
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunodiagnosis of snake venom poisoning.
    Ratanabanangkoon K; Billings PB; Matangkasombut P
    Asian Pac J Allergy Immunol; 1987 Dec; 5(2):187-90. PubMed ID: 3329521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of IgY(DeltaFc) antibody based neuro toxin antivenoms and the study on their neutralization efficacies.
    Chiou VY
    Clin Toxicol (Phila); 2008 Jul; 46(6):539-44. PubMed ID: 18584367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the method of determining the effect of antimyonecrotic factor antibody in Habu-antivenin [proceedings].
    Chinzei H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):204-5. PubMed ID: 682381
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of low-dose snake antivenom in severe neurotoxic snake envenoming.
    Singh A; Agarwal R
    Am J Emerg Med; 2008 Nov; 26(9):1058-9. PubMed ID: 19091272
    [No Abstract]   [Full Text] [Related]  

  • 20. High or low- a trial of low dose anti snake venom in the treatment of poisonous snakebites.
    Cherian AM; Girish TS; Jagannati M; Lakshmi M
    J Assoc Physicians India; 2013 Jun; 61(6):387-9, 396. PubMed ID: 24640204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.